19 results
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
established – groundbreaking to complete validation in 2 years Design Build Operations Nov 8, 2021 Groundbreaking Nov 25, 2022 First clean room operational May
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
us to manufacture both commercial and clinical autologous drug products in the facility. The Nucleus provides multiple clean rooms, QC labs, warehouse
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
13 Feb 24
Regulation FD Disclosure
4:06pm
+ batches per year Target vein to delivery time 16 days at launch Nov 8, 2021 Groundbreaking Nov 25, 2022 First clean room operational May 2023 Capacity
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
subsidiaries and (D) there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
subsidiaries and (D) there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation
10-Q
EX-10.1
yp4ifa91
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.1
nkyvzd830mbl3
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
rj6jiylbpyqjb71pg7a
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
3lfs9
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-1.1
kmnodqp
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K/A
EX-99.2
8q8bawhywxe3j 0uz5o
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.3
e7cgoi5vq 2f7
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
b3s2cjjmxg
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.1
fu01w4go3d y2vau4vir
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1.1
hq5b7pwb
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
e6eqnafhlsb8s ojmf
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
CORRESP
plwz3ec26
19 Jun 18
Correspondence with SEC
12:00am
CORRESP
w0fhk207
8 Jun 18
Correspondence with SEC
12:00am
CORRESP
q74al8jrhak20qosy64
10 May 18
Correspondence with SEC
12:00am
- Prev
- 1
- Next